LEADER 01478nam  2200397z- 450 
001 9910694394303321
005 20070413083500.0
035   $a(CKB)5860000000030801
035   $a(BIP)014080485
035   $a(EXLCZ)995860000000030801
100   $a20220406c2007uuuu  -u-         -
101 0 $aeng
200 10$aPaying off generics to prevent competition with brand name drugs $eshould it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007
215   $a1 online resource (iii, 180 p.) $cill
311   $a0-16-078352-6 
517   $aPaying off Generics to Prevent Competition with Brand Name Drugs
606   $aDrugs$xPrices$zUnited States
606   $aGeneric drugs$xPrices$zUnited States
606   $aPharmaceutical industry$zUnited States
606   $aCompetition, Unfair$zUnited States
610   $aDrugs
610   $aGeneric drugs
610   $aPharmaceutical industry
610   $aCompetition, unfair
610   $aMedical
610   $aBusiness & economics
610   $aLaw
615  0$aDrugs$xPrices
615  0$aGeneric drugs$xPrices
615  0$aPharmaceutical industry
615  0$aCompetition, Unfair
712 02$aUnited States, Congress Senate Committee on the Judiciary Staff,$4oth
906   $aBOOK
912   $a9910694394303321
996   $aPaying off generics to prevent competition with brand name drugs$93208307
997   $aUNINA